Author Archives: Matt Fisher

About Matt Fisher

Matt is the chair of Mirick O'Connell's Health Law Group and a partner in the firm's Business Group. Matt focuses his practice on health law and all areas of corporate transactions. Matt's health law practice includes advising clients with regulatory, fraud, abuse, and compliance issues. With regard to regulatory matters, Matt advises clients to ensure that contracts, agreements and other business arrangements meet both federal and state statutory and regulatory requirements. Matt's regulatory advice focuses on complying with requirements of the Stark Law, Anti-Kickback Statute, fraud and abuse regulations, licensing requirements and HIPAA. Matt also advises clients on compliance policies to develop appropriate monitoring and oversight of operations.

Reminder, Provide Access to Data

Another Settlement The Office for Civil Rights started 2021 off with another settlement of alleged non-compliance with the HIPAA right of access. The settlement, as noted by OCR, is the 14th right of access settlement since OCR began its targeted … Continue reading

Posted in Compliance, HIPAA, Healthcare, Business, Health IT, Regulations, EHR, EMR | Tagged , , , , , | Leave a comment

Looking Ahead: Promise After a Tumultuous Year

Every year brings its own successes and trials, but 2020 brought more than its fair share of trials. The biggest issue that dominated healthcare throughout the year (and will continue to do so into 2021) was COVID-19. The unexpected, swift, … Continue reading

Posted in ACO, Business, Compliance, Health IT, Healthcare, HIPAA, Physicians, Regulations | Tagged , , , , | Leave a comment

HIPAA Progress: Incremental or By a Leap?

After a bit longer of a delay than was initially expected, the Department of Health and Human Services released a proposed rule to change pieces of HIPAA. The proposed rule is the outcome from a request for information that closed … Continue reading

Posted in Business, Compliance, Health IT, Healthcare, HIPAA, Regulations | Tagged , , , , , , , , | Leave a comment